Neuronal damage

Neuronal damage refers to the structural or functional impairment of neurons, serving as a central pathological endpoint in many central nervous system disorders (StatPearls, 2023). It is not a single molecular target such as a specific receptor or enzyme; rather, it represents a complex cascade of events including excitotoxicity, oxidative stress, mitochondrial dysfunction, and neuroinflammation (PubMed, 2022). Therapeutic strategies, broadly termed 'neuroprotection,' focus on preserving neuronal integrity by intervening in these destructive pathways to limit further loss (NIH, 2021). Drugs such as Memantine, Riluzole, and Edaravone are utilized to mitigate specific triggers like excessive glutamate signaling or free radical damage (PubMed, 2021). The assessment of neuronal damage in clinical settings increasingly relies on fluid biomarkers like neurofilament light chain (NfL), which is released into the cerebrospinal fluid and blood upon axonal injury (Nature Reviews Neurology, 2020). Developing effective therapies remains highly challenging due to the intricate nature of the brain and the necessity for drugs to penetrate the blood-brain barrier effectively (NIH, 2022).

Other names

NeurodegenerationNeuronal injuryNeuronal lossNeurotoxicityBrain injuryNerve cell damage

Therapeutic interventions targeting neuronal damage focus on neuroprotection by inhibiting NMDA receptor excitotoxicity, scavenging free radicals, modulating glutamate release, or stabilizing mitochondrial function to prevent the cascade leading to programmed cell death.